Speculation on Biomet Sale

Shares of Biomet, which makes artificial hips and knees, rose 9.7 percent yesterday on speculation that the company might be sold. Speculation began last week after a founder, Dane A. Miller, resigned as chief executive, and it intensified after CNBC reported that Biomet had hired Morgan Stanley to explore strategic alternatives.